# Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

> **NCT01432080** · PHASE2 · TERMINATED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 12 (actual)

## Conditions studied

- Respiratory Tract Infections
- Bronchiolitis Obliterans
- Cryptogenic Organizing Pneumonia
- Lung Diseases, Interstitial

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Azithromycin
- **DRUG:** Montelukast
- **DRUG:** Symbicort

## Key facts

- **NCT ID:** NCT01432080
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-12-30
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Not meeting recruitment targets
- **Last updated:** 2021-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432080, "Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01432080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*